BOTHELL,
Wash., Nov. 2, 2023 /PRNewswire/ -- BioLife
Solutions, Inc. (NASDAQ: BLFS), a leading supplier of
class-defining bioproduction tools and services for the cell and
gene therapies ("CGT") and broader biopharma markets, today
announced the Company's third quarter financial results will be
released after market close on Thursday,
November 9, 2023. The Company will host a conference call
and live webcast at 4:30pm ET
(1:30pm PT) that day. Management will
provide an overview of the Company's financial results and a
general business update.
To access the webcast, log onto the Investor Relations page of
the BioLife Solutions website
at https://www.biolifesolutions.com/earnings. In
addition, the conference call will be accessible by dialing
toll-free (800) 715-9871. The conference ID number is 5946398.
A webcast replay will be available approximately two hours after
the call and will be archived
on https://www.biolifesolutions.com/ for 90 days.
About BioLife Solutions
BioLife Solutions is a leading
supplier of class-defining bioproduction tools and services for the
cell and gene therapy (CGT) and broader biopharma markets. Our
expertise facilitates the commercialization of new therapies by
supplying solutions that maintain the health and function of
biologic materials during collection, development, storage, and
distribution. For more information, please visit
www.biolifesolutions.com or follow BioLife on LinkedIn and X.
Media & Investor Relations
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-provide-third-quarter-2023-financial-results-and-business-update-on-november-9-2023-301976431.html
SOURCE BioLife Solutions, Inc.